SegueTX-Pancreatic Cancer, L.L.C.

Biotechnology company · Shreveport, Louisiana, United States

SegueTX-Pancreatic Cancer, L.L.C. is a biotechnology company headquartered in Shreveport, Louisiana, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $274,999 in total, most recently in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

SegueTX-Pancreatic Cancer at a glance

Typebiotechnology company

HeadquartersShreveport, Louisiana, United States

Employees (self-reported, 2019)3

What does SegueTX-Pancreatic Cancer do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $274,999 in total (2019). NIH funding came from the National Heart, Lung, and Blood Institute.

Frequently asked questions about SegueTX-Pancreatic Cancer

Where is SegueTX-Pancreatic Cancer headquartered?

SegueTX-Pancreatic Cancer, L.L.C. is headquartered in Shreveport, Louisiana, United States.

What does SegueTX-Pancreatic Cancer do?

SegueTX-Pancreatic Cancer, L.L.C. is a biotechnology company.

Similar companies

Calosyn Pharma, Inc.Shreveport, Louisiana, United States
Oleolive, Inc.Shreveport, Louisiana, United States
Starget Pharma Inc.Shreveport, Louisiana, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences